MICROMET, INC. (MITI) [Rocket]

Date Filed	Type	Description
02/03/2012	PRN	Buyout Offer for Micromet Triggers Shareholder-Claim Investigation by Goldfarb LLP Securities Attorneys
02/02/2012	PRN	Bull & Lifshitz, LLP Announces Investigation of Micromet, Inc.
07/11/2011	BW	Micromet Announces Solid Tumor BiTE Antibody Collaboration with Amgen
06/06/2011	BW	Micromet to Present at Two Upcoming Investor Conferences
05/23/2011	BW	Micromet to Report Blinatumomab Data at June Medical Conferences
05/17/2011	BW	Data Published in Journal of Clinical Oncology Highlights Significant Activity of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia
05/10/2011	BW	Micromet Reports First Quarter 2011 Financial Results and Highlights Near-Term Milestones
05/04/2011	BW	Micromet to Report First Quarter 2011 Financial Results on May 10
04/05/2011	BW	BiTE Antibody MT112/BAY 2010112 Demonstrates Potent Activity against Human Prostate Cancer Cells
03/28/2011	BW	Micromet to Present at Two Upcoming Investor Conferences
03/03/2011	BW	Micromet Reports Fourth Quarter and Full Year 2010 Financial Results and Provides 2011 Outlook
02/25/2011	BW	Micromet to Report Fourth Quarter and Full Year 2010 Financial Results on March 3
02/17/2011	BW	Micromet to Present at Two Upcoming Investor Conferences
12/06/2010	BW	Micromet's Blinatumomab Produces High Objective Response Rate in Spectrum of Relapsed Non-Hodgkin's Lymphoma Patients
12/06/2010	BW	Long-Term Follow-Up Data from Phase 2 Study Show Micromet's Blinatumomab Produces Durable Remissions in Patients with Acute Lymphoblastic Leukemia
11/30/2010	BW	Micromet to Present at the 2010 Piper Jaffray Healthcare Conference
11/16/2010	BW	Micromet Closes $70.5 Million Public Offering of Common Stock
11/11/2010	BW	Micromet Announces Pricing of Public Offering of 9.9 Million Shares of Common Stock
11/10/2010	BW	Micromet Announces the Sale of Common Stock
11/09/2010	BW	Micromet Reports Third Quarter 2010 Financial Results
11/09/2010	BW	Micromet to Provide Update on BiTE Antibody R&D Programs at 2010 American Society of Hematology Annual Meeting
11/08/2010	BW	Micromet to Advance BiTE Antibody MT112/BAY 2010112 into IND-Enabling Preclinical Development Activities in Collaboration with Bayer Schering Pharma
10/19/2010	BW	Micromet to Report Third Quarter 2010 Financial Results on November 9
10/18/2010	BW	Micromet to Present at the 2010 Newsmakers in the Biotechnology Industry Conference
09/20/2010	BW	Micromet Initiates Phase 2 Trial of Blinatumomab in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
09/15/2010	BW	Micromet to Present at the 2010 UBS Global Life Sciences Conference